PART I Overview We are a United States based biopharmaceutical company engaging in the development, manufacturing, and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The Companys products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamp series (together, the RhodoLED Lamps), are used for the treatment of actinic keratosis (AK), a common skin condition characterized by the growth of pre-c...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-19 | 2025-12-31 | 0001493152-26-011625 | EDGAR | 63K words |
| 2025-03-20 | 2024-12-31 | 0001493152-25-011052 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0001493152-24-010133 | EDGAR | — |
| 2023-03-13 | 2022-12-31 | 0001493152-23-007472 | EDGAR | — |
| 2022-04-11 | 2021-12-31 | 0001493152-22-009519 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001493152-25-021945 | EDGAR | 27K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023486 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001641172-25-011031 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045220 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001493152-24-032216 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019878 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040132 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001493152-23-027701 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016636 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031682 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001493152-22-022202 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001493152-22-013163 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-19 | 0001493152-26-011545 | EDGAR | 5K words |
| 2026-03-09 | 0001493152-26-009321 | EDGAR | — |
| 2026-02-26 | 0001493152-26-008136 | EDGAR | — |
| 2026-02-09 | 0001493152-26-005717 | EDGAR | — |
| 2026-01-13 | 0001493152-26-001959 | EDGAR | — |
| 2026-01-07 | 0001493152-26-000823 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022133 | EDGAR | — |
| 2025-11-10 | 0001493152-25-021525 | EDGAR | — |
| 2025-11-07 | 0001493152-25-021189 | EDGAR | — |
| 2025-10-24 | 0001493152-25-019370 | EDGAR | — |
151 total filings indexed. 124 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001858685 |
| Ticker | BFRI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.biofrontera-us.com |
| Listed | 2021-10-29 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report